Certain prescriptions can influence physiological readings, and this full guide details which medications matter and how they are accounted for during a lie detector test.
A comprehensive, evidence-based guide covering every major medication class that can alter cardiovascular, respiratory, and electrodermal responses during polygraph testing. Essential reading for examinees, examiners, and attorneys evaluating polygraph evidence.
TL;DR — The Short Version
- Beta-blockers suppress heart rate and blood pressure responses, dampening the cardiovascular channel and potentially leading to inconclusive results rather than false outcomes.
- Benzodiazepines globally suppress central nervous system activity, reducing electrodermal, cardiovascular, and respiratory reactivity across all channels simultaneously.
- Antidepressants vary by class — SSRIs may reduce EDA, SNRIs can elevate cardiovascular baselines, and tricyclics cause anticholinergic effects that suppress skin conductance.
- Stimulants elevate baseline arousal across all channels, making it harder to differentiate between general anxiety and deception-related responses.
- First-generation OTC antihistamines cause sedation and reduced electrodermal activity similar to benzodiazepines.
- Opioids depress respiratory rate and depth, suppressing pneumograph readings and overall autonomic reactivity.
- Always disclose every medication, supplement, and substance to your examiner before testing — this is essential for valid results.
- Never stop or change prescribed medications to influence your test. This is medically dangerous and an experienced examiner may recognise it as a countermeasure attempt.
Who This Guide Is For
- Anyone preparing for a polygraph test who takes prescription or OTC medications
- Polygraph examiners conducting pre-test suitability assessments
- Attorneys reviewing polygraph results where medication is a factor
- PCSOT professionals working with examinees on ongoing medication regimens
- Law enforcement candidates on prescription medications facing pre-employment screening
- Therapists and counsellors whose clients are scheduled for polygraph examinations
How a Polygraph Measures Physiological Responses
The Three Primary Physiological Channels
To understand how medications influence polygraph results, it is essential to understand what the polygraph actually measures. A polygraph instrument simultaneously records activity across three primary physiological channels, each of which can be affected by different classes of drugs [1]Verified The Polygraph and Lie Detection
Confirms that drug effects on polygraph outcomes have received limited experimental attention and that different drug classes likely affect different physiological responses. The National Research Council has acknowledged that drug effects on polygraph outcomes have received relatively limited experimental attention, making this guide a critical resource for all parties involved.
The cardiovascular channel uses a blood pressure cuff (cardio cuff) placed on the upper arm to measure relative changes in blood pressure, heart rate, and pulse amplitude. When a person experiences stress or arousal — which polygraph theory associates with deception — the cardiovascular system typically responds with increased heart rate, elevated blood pressure, and changes in pulse wave patterns [2]Verified Beyond the Polygraph: Deception Detection and the Autonomic Nervous System
Confirms beta-blockers reduce heart rate, heart rate variability, cardiac contractility, and blood pressure; documents that 5 of 10 most prescribed medications in 2016 had direct ANS effects; covers mefloquine and multiple medication classes affecting polygraph. Krapf and Nevin's important 2019 study in Military Medicine confirmed that of the 10 most prescribed medications in 2016, five had direct effects on the autonomic nervous system or autonomic end-organs [2]Verified Beyond the Polygraph: Deception Detection and the Autonomic Nervous System
Confirms beta-blockers reduce heart rate, heart rate variability, cardiac contractility, and blood pressure; documents that 5 of 10 most prescribed medications in 2016 had direct ANS effects; covers mefloquine and multiple medication classes affecting polygraph. Any medication that alters heart rate or blood pressure can directly influence data recorded on this channel.
The respiratory channel employs pneumograph tubes (typically two: one thoracic and one abdominal) that measure the rate, depth, and regularity of breathing. Deception is theorised to produce changes in respiratory patterns, such as suppressed breathing, irregular rhythms, or changes in the ratio of inhalation to exhalation. Any substance affecting the respiratory centre in the brainstem or breathing mechanics can influence these readings.
The electrodermal activity (EDA) channel — also known as galvanic skin response (GSR) or skin conductance — measures the electrical conductivity of the skin via finger plates or electrodes. As Handler, Nelson, Krapohl, and Honts documented in their landmark paper, the electrodermal response (EDR) is the most robust and informative of all polygraph signals, with several studies indicating it provides the greatest contribution to diagnostic accuracy [3]Verified An EDA Primer for Polygraph Examiners
Confirms that the electrodermal response is the most robust and informative polygraph signal, and documents anticholinergic medication effects on EDA. Sweat gland activity is controlled by the sympathetic nervous system and is one of the most sensitive indicators of arousal. Medications affecting the sympathetic nervous system or sweat glands can alter EDA readings significantly.
What the Polygraph Is Actually Detecting
The polygraph detects physiological changes associated with the autonomic nervous system's response to stress or significance. The examiner compares responses to relevant questions (about the issue being investigated) against responses to comparison questions (about broader behaviours unrelated to the specific issue). Differential reactivity between these question types forms the basis for scoring.
Medications can influence this process in two fundamental ways. First, they can suppress physiological responses, making it difficult for the examiner to detect the differential reactivity needed for accurate scoring. Second, they can elevate or distort baseline arousal levels, creating noise that obscures the signal the examiner is looking for. Either scenario can lead to inconclusive results. Research has demonstrated that the examiner's approach and methodology are critical factors in producing accurate outcomes [4]Verified Examiner Approach and its Impact on Polygraph Results
Confirms that examiner approach significantly impacts polygraph validity and that providing information to examinees does not impair test accuracy.
The pretest interview is where medication status is assessed, and it plays a vital role in ensuring valid results. An experienced examiner who knows about an examinee's medication can adapt their interpretation methodology accordingly. For more information on how test conditions affect outcomes, see our guide on ideal conditions for a lie detector test. Research has also shown that providing examinees with detailed test information does not significantly affect validity [5]Verified Information Does Not Affect the Validity of a Comparison Question Test
Demonstrates that providing examinees with detailed CQT information and countermeasure instructions did not significantly affect test validity, demonstrating the robustness of properly administered polygraph examinations.
Why Medications Matter in Polygraph Testing
The Autonomic Nervous System Connection
Every physiological channel measured by the polygraph is controlled, at least in part, by the autonomic nervous system (ANS). The ANS has two branches: the sympathetic nervous system (SNS), which governs the "fight-or-flight" response, and the parasympathetic nervous system (PNS), which governs "rest-and-digest" functions. The interplay between these two systems produces the physiological changes the polygraph records.
Most medications that affect polygraph results do so because they act on the autonomic nervous system or on the end organs it controls. A beta-blocker blocks the effect of adrenaline on the heart, preventing the normal cardiovascular response to stress. A benzodiazepine enhances the inhibitory neurotransmitter GABA, broadly dampening CNS and ANS activity. An anticholinergic drug blocks acetylcholine receptors, affecting sweat gland function and therefore EDA [3]Verified An EDA Primer for Polygraph Examiners
Confirms that the electrodermal response is the most robust and informative polygraph signal, and documents anticholinergic medication effects on EDA. As Krapf and Nevin (2019) documented in Military Medicine, many commonly prescribed medications have effects on the ANS that could affect the results of a polygraph examination [2]Verified Beyond the Polygraph: Deception Detection and the Autonomic Nervous System
Confirms beta-blockers reduce heart rate, heart rate variability, cardiac contractility, and blood pressure; documents that 5 of 10 most prescribed medications in 2016 had direct ANS effects; covers mefloquine and multiple medication classes affecting polygraph.
The American Polygraph Association (APA) and polygraph training curricula emphasise that medication status must be assessed during the pre-test interview. Examiners who fail to properly evaluate medication effects risk producing unreliable results, which has implications for both the examinee and the integrity of the examination process. For details on how polygraph questions are reviewed before the test, consult our dedicated guide.
Prevalence of Medication Use Among Examinees
The significance of this issue is underscored by the prevalence of medication use in the general population. According to the CDC's National Center for Health Statistics, approximately 45.8% of the U.S. population used at least one prescription drug in the past 30 days during 2015–2016 [6]Verified Prescription Drug Use in the United States, 2015–2016 (NCHS Data Brief No. 334)
Confirms 45.8% of U.S. population used one or more prescription drugs in past 30 days; 85.0% of adults aged 60+ used prescription drugs; antidepressants used by 11.4% of adults aged 20–59. Prescription drug use increased with age, from 18.0% of children under age 12 to 85.0% of adults aged 60 and over [6]Verified Prescription Drug Use in the United States, 2015–2016 (NCHS Data Brief No. 334)
Confirms 45.8% of U.S. population used one or more prescription drugs in past 30 days; 85.0% of adults aged 60+ used prescription drugs; antidepressants used by 11.4% of adults aged 20–59. Among the most commonly prescribed medication classes for adults aged 20–59 are antidepressants (11.4%), while lipid-lowering drugs are the most commonly used by adults aged 60 and over [6]Verified Prescription Drug Use in the United States, 2015–2016 (NCHS Data Brief No. 334)
Confirms 45.8% of U.S. population used one or more prescription drugs in past 30 days; 85.0% of adults aged 60+ used prescription drugs; antidepressants used by 11.4% of adults aged 20–59. Several of these drug classes have the potential to influence polygraph readings.
For older examinees, the prevalence of multiple medication use is considerably higher. CDC data from the National Health and Nutrition Examination Survey shows that for adults aged 65 and older, 43.0% were taking five or more prescription drugs in the 2017–March 2020 period, representing a significant increase from 33.3% in 2001–2004 [7]Verified Prescription Drug Use - Health, United States (Trends)
Confirms adults 65+ using five or more prescription drugs increased from 33.3% to 43.0% between 2001–2004 and 2017–March 2020. The Lown Institute has reported that more than four in ten older adults take five or more prescription medications, representing a tripling from twenty years ago [8]Verified Medication Overload and Older Americans
Confirms more than four in ten older adults take five or more prescription medications, triple the rate from twenty years ago. Research published in JAMA similarly confirmed that more than 4 out of every 10 adults aged 65 or older reported using 5 or more prescription medications between 2017 and 2020 [9]Verified Polypharmacy Nearly Doubled in 20 Years Among Older Adults in US
Confirms more than 4 out of 10 adults 65+ reported using 5 or more prescription medications between 2017 and 2020.
Given these statistics, it is virtually inevitable that a significant percentage of polygraph examinees will be taking one or more medications that could affect their physiological responses. This makes the medication assessment a non-negotiable component of professional polygraph practice.
Beta-Blockers and Cardiovascular Suppressants
How Beta-Blockers Affect the Polygraph
Beta-adrenergic antagonists (beta-blockers) are among the most studied medications in the context of polygraph testing and are widely regarded as one of the most impactful drug classes on polygraph accuracy. These medications work by blocking beta-adrenergic receptors in the heart and blood vessels, preventing the normal cardiovascular response to epinephrine (adrenaline) and norepinephrine.
Common beta-blockers include propranolol (Inderal), a non-selective beta-blocker also used off-label for performance anxiety; atenolol (Tenormin), a cardioselective beta-1 blocker; metoprolol (Lopressor, Toprol-XL), one of the most commonly prescribed; nadolol (Corgard); carvedilol (Coreg), a combined alpha and beta-blocker; and bisoprolol (Zebeta).
Research published in Military Medicine confirms that beta-blockers reduce beta-adrenergic receptor activation in cardiac muscle and blood vessels, decreasing heart rate, heart rate variability, cardiac contractility, and blood pressure [2]Verified Beyond the Polygraph: Deception Detection and the Autonomic Nervous System
Confirms beta-blockers reduce heart rate, heart rate variability, cardiac contractility, and blood pressure; documents that 5 of 10 most prescribed medications in 2016 had direct ANS effects; covers mefloquine and multiple medication classes affecting polygraph. A patient taking beta-blockers will therefore have a blunted physiological response to stress and an increased likelihood of an inconclusive or false-negative polygraph examination [2]Verified Beyond the Polygraph: Deception Detection and the Autonomic Nervous System
Confirms beta-blockers reduce heart rate, heart rate variability, cardiac contractility, and blood pressure; documents that 5 of 10 most prescribed medications in 2016 had direct ANS effects; covers mefloquine and multiple medication classes affecting polygraph. This is particularly relevant given that beta-blockers are prescribed for conditions including congestive heart failure, hypertension, panic disorder, and PTSD [2]Verified Beyond the Polygraph: Deception Detection and the Autonomic Nervous System
Confirms beta-blockers reduce heart rate, heart rate variability, cardiac contractility, and blood pressure; documents that 5 of 10 most prescribed medications in 2016 had direct ANS effects; covers mefloquine and multiple medication classes affecting polygraph.
Specific Effects on Polygraph Channels
Cardiovascular channel: Beta-blockers directly suppress the heart's ability to respond to sympathetic stimulation. Heart rate remains relatively stable regardless of emotional state, blood pressure responses are blunted, and pulse amplitude changes are minimised. The cardiovascular channel may show a "flat" or non-reactive tracing that provides insufficient data for comparison.
Electrodermal activity: Beta-blockers have a variable effect on EDA. Non-selective beta-blockers like propranolol can reduce sympathetically mediated sweating, though this effect is generally less pronounced than the cardiovascular suppression. A study conducted by the Scientific Interrogation Unit of the Israeli Police and the Department of Cardiology of the Ichilov Medical Center found that the GSR channel was the most efficient identification index but was also the most vulnerable to the effect of the beta-blocking agent Trasicor [10]Verified Effects of Beta Blocking Drugs on the Polygraph Detection Rate: A Pilot Study
Confirms GSR channel was most vulnerable to beta-blocker effects while respiration channel maintained above-chance identification; conducted by the Scientific Interrogation Unit of the Israeli Police. Cardioselective beta-blockers (atenolol, metoprolol) typically have minimal direct effect on EDA.
Respiratory channel: Beta-blockers, particularly non-selective ones, can cause mild bronchospasm in susceptible individuals, potentially affecting respiratory patterns. However, the respiratory channel is generally the least impacted. The same Israeli Police study found that the respiration channel maintained identification at a level better than chance even under beta-blocker influence, and this accuracy was not diminished by the beta-blocking agent [10]Verified Effects of Beta Blocking Drugs on the Polygraph Detection Rate: A Pilot Study
Confirms GSR channel was most vulnerable to beta-blocker effects while respiration channel maintained above-chance identification; conducted by the Scientific Interrogation Unit of the Israeli Police.
Why Beta-Blockers Are of Interest to Examiners
Beta-blockers are of particular concern in the polygraph field because propranolol has been discussed in the context of polygraph countermeasures. The OTA (Office of Technology Assessment) reviewed a study by Gatchel et al. and found that propranolol use resulted in a 32.2-percent inconclusive rate, although the overall error rate was low [11]Verified Scientific Validity of Polygraph Testing: A Research Review and Evaluation
Confirms Gatchel et al. propranolol study showing 32.2% inconclusive rate with low overall error rate; examiners could not detect drug use in subjects; diazepam and methylphenidate did not affect detection accuracy. Importantly, examiners could not tell which subjects had used the drug [11]Verified Scientific Validity of Polygraph Testing: A Research Review and Evaluation
Confirms Gatchel et al. propranolol study showing 32.2% inconclusive rate with low overall error rate; examiners could not detect drug use in subjects; diazepam and methylphenidate did not affect detection accuracy. The OTA also found that the use of tranquilisers in a comparison question test would be more likely to yield inconclusive findings rather than errors, because the drugs would likely result in no difference between responses to control and relevant questions [11]Verified Scientific Validity of Polygraph Testing: A Research Review and Evaluation
Confirms Gatchel et al. propranolol study showing 32.2% inconclusive rate with low overall error rate; examiners could not detect drug use in subjects; diazepam and methylphenidate did not affect detection accuracy.
However, an experienced examiner can often recognise the characteristic cardiovascular suppression associated with beta-blocker use — unusually stable heart rate and blood pressure with minimal reactivity to any question type. If you are on a legitimate beta-blocker prescription, full disclosure during the pretest interview allows the examiner to account for these effects. The importance of properly calibrated and maintained equipment cannot be overstated in detecting subtle physiological changes in medicated examinees.
Benzodiazepines and Sedatives
Mechanism and Common Benzodiazepines
Benzodiazepines enhance the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABA-A receptor, producing sedative, anxiolytic, muscle-relaxant, and hypnotic effects. Because they broadly suppress central nervous system activity, their impact on polygraph testing is pervasive and affects all three physiological channels.
Commonly prescribed benzodiazepines include alprazolam (Xanax), a short-acting medication for anxiety and panic disorder; diazepam (Valium), long-acting for anxiety, muscle spasms, and seizures; lorazepam (Ativan), intermediate-acting for anxiety; clonazepam (Klonopin), long-acting for seizures and panic disorder; temazepam (Restoril), primarily for insomnia; and chlordiazepoxide (Librium), used for alcohol withdrawal.
Effects Across All Three Polygraph Channels
Electrodermal activity: Benzodiazepines significantly reduce skin conductance responses by dampening sympathetic nervous system output. The EDA channel may show reduced amplitude, slower recovery times, and decreased frequency of non-specific responses. This is often the most visibly affected channel.
Cardiovascular channel: Heart rate and blood pressure responses are suppressed, though typically to a lesser degree than with beta-blockers. The cardiovascular tracing may show reduced reactivity with less distinct changes between question types.
Respiratory channel: Benzodiazepines can cause respiratory depression, slowing the breathing rate and reducing depth. This can alter respiratory patterns in ways that complicate interpretation.
The OTA report noted that some countermeasures, such as the use of psychoactive drugs like diazepam, have broad behavioural consequences. Notably, a study by Iacono et al. reviewed in the OTA report found that ingestion of neither 10 milligrams of diazepam (Valium) nor 20 milligrams of methylphenidate (Ritalin) affected the accuracy of detection in a guilty knowledge test paradigm [11]Verified Scientific Validity of Polygraph Testing: A Research Review and Evaluation
Confirms Gatchel et al. propranolol study showing 32.2% inconclusive rate with low overall error rate; examiners could not detect drug use in subjects; diazepam and methylphenidate did not affect detection accuracy. The primary concern with benzodiazepines in comparison question testing is their "global dampening" effect — they suppress reactivity across all channels simultaneously, making it difficult to detect differential reactivity between question types. For examinees dealing with anxiety related to substance abuse issues, proper disclosure is especially important.
Non-Benzodiazepine Sedatives
Several non-benzodiazepine sedatives can produce similar effects: zolpidem (Ambien), where residual effects can persist if taken within 8–12 hours of testing; eszopiclone (Lunesta), with similar residual effects; buspirone (Buspar), a 5-HT1A partial agonist that can reduce anxiety without the same degree of global CNS suppression; gabapentin (Neurontin), which can cause sedation and altered physiological responses at higher doses; and pregabalin (Lyrica), which can cause sedation and reduced autonomic reactivity.
Importantly, research by Mickoś and Leśniak (2021) published in European Polygraph found that 24-hour sleep deprivation did not significantly reduce polygraph detection accuracy, and energy drink consumption did not alter test outcomes [12]Verified On the Influence of Sleep Deprivation on the Results of Polygraph Testing
Confirms that 24-hour sleep deprivation effects on polygraph testing accuracy were studied; energy drink consumption was also assessed. This suggests that sleep aids taken the night before testing may have less impact than commonly feared, particularly when the examinee has had adequate sleep.
Antidepressants: SSRIs, SNRIs, and Tricyclics
Selective Serotonin Reuptake Inhibitors (SSRIs)
SSRIs are the most commonly prescribed class of antidepressants, with CDC data showing antidepressants are among the top prescribed drug types for U.S. adults aged 20–59, used by 11.4% of this population [6]Verified Prescription Drug Use in the United States, 2015–2016 (NCHS Data Brief No. 334)
Confirms 45.8% of U.S. population used one or more prescription drugs in past 30 days; 85.0% of adults aged 60+ used prescription drugs; antidepressants used by 11.4% of adults aged 20–59. They include sertraline (Zoloft), fluoxetine (Prozac), escitalopram (Lexapro), paroxetine (Paxil), citalopram (Celexa), and fluvoxamine (Luvox).
SSRIs work by blocking the reuptake of serotonin in the brain. Their effects on polygraph testing are generally more subtle than those of beta-blockers or benzodiazepines. SSRIs can reduce EDA responsiveness, as serotonin modulates sympathetic nervous system output, dampening the sympathetic drive that produces sweat gland activation. SSRIs generally have minimal direct cardiovascular effects, though some (particularly paroxetine and fluoxetine) can cause slight heart rate changes. Their effect on respiration is negligible.
Antidepressant medication, including SSRIs, may further reduce physiological reactivity in individuals already experiencing blunted autonomic response from depression, potentially leading to less reactive charts [13]Verified Medical and Psychological Conditions Affecting Polygraph Examinations
Confirms that antidepressant medication may further reduce physiological reactivity in depression and that testing is contraindicated with active psychoactive substance influence. For a broader understanding of how mental health conditions affect polygraph testing, see our guides on bipolar disorder and polygraph tests and schizophrenia and lie detector tests. Most examinees on stable SSRI doses can be tested successfully by an experienced examiner.
Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
SNRIs block the reuptake of both serotonin and norepinephrine, giving them a dual mechanism with more pronounced effects on the autonomic nervous system than SSRIs alone. They include venlafaxine (Effexor), duloxetine (Cymbalta), desvenlafaxine (Pristiq), and levomilnacipran (Fetzima).
Cardiovascular channel: The norepinephrine reuptake inhibition can elevate resting blood pressure and heart rate, particularly at higher doses. Venlafaxine is well-documented to cause dose-dependent hypertension, creating elevated baselines that complicate comparison between question types.
Electrodermal activity: The noradrenergic component can increase sweating at baseline, potentially creating a higher tonic EDA level that reduces the relative magnitude of phasic responses to individual questions.
Respiratory channel: SNRIs generally have minimal direct effects on respiratory patterns.
Tricyclic Antidepressants (TCAs)
Tricyclic antidepressants — including amitriptyline (Elavil), nortriptyline (Pamelor), imipramine (Tofranil), and desipramine (Norpramin) — have significant anticholinergic properties that are particularly relevant to polygraph testing.
The anticholinergic effects of TCAs directly suppress sweat gland function, reducing EDA significantly. As Handler, Nelson, Krapohl, and Honts documented, anticholinergic medication effects on EDA represent a significant concern for polygraph interpretation [3]Verified An EDA Primer for Polygraph Examiners
Confirms that the electrodermal response is the most robust and informative polygraph signal, and documents anticholinergic medication effects on EDA. TCAs also cause cardiovascular effects including increased resting heart rate, orthostatic hypotension, and potential cardiac conduction changes. These combined effects make TCAs one of the more problematic drug classes for polygraph testing, though an informed examiner can still work effectively with medicated examinees.
Stimulants and ADHD Medications
How Stimulants Affect Polygraph Testing
Stimulant medications prescribed for ADHD and related conditions represent a unique challenge for polygraph testing because they elevate baseline arousal rather than suppress it. Common stimulants include amphetamine/dextroamphetamine (Adderall), methylphenidate (Ritalin, Concerta), lisdexamfetamine (Vyvanse), and dextroamphetamine (Dexedrine).
Stimulants increase sympathetic nervous system activity, elevating heart rate, blood pressure, and sweat gland activity across the board. This creates a "noisy" baseline where the examiner must distinguish between deception-related arousal and the pharmacologically induced heightened state.
Cardiovascular channel: Elevated resting heart rate and blood pressure, with reduced dynamic range for further increases in response to individual questions.
Electrodermal activity: Increased tonic skin conductance level with potentially more frequent non-specific responses, reducing the signal-to-noise ratio.
Respiratory channel: May show slightly increased respiratory rate but generally less affected than other channels.
Notably, the OTA 1983 review cited research by Iacono et al. showing that methylphenidate (Ritalin) at 20 milligrams did not affect the accuracy of polygraph detection in a guilty knowledge test paradigm [11]Verified Scientific Validity of Polygraph Testing: A Research Review and Evaluation
Confirms Gatchel et al. propranolol study showing 32.2% inconclusive rate with low overall error rate; examiners could not detect drug use in subjects; diazepam and methylphenidate did not affect detection accuracy. This provides reassurance that therapeutic doses of ADHD medications may not prevent accurate testing in the hands of a skilled examiner.
Antihypertensive and Cardiovascular Medications
Beyond Beta-Blockers: Other Cardiovascular Drugs
Several classes of cardiovascular medications beyond beta-blockers can influence polygraph results:
ACE inhibitors (lisinopril, enalapril, ramipril) and ARBs (losartan, valsartan) lower blood pressure through the renin-angiotensin system. Their effects on polygraph testing are generally less pronounced than beta-blockers because they do not directly block sympathetic nervous system activity. However, they can reduce the magnitude of blood pressure responses to stress.
Calcium channel blockers (amlodipine, diltiazem, verapamil) reduce blood pressure and, in the case of non-dihydropyridines like verapamil and diltiazem, can also lower heart rate. Verapamil in particular can produce effects similar to beta-blockers on the cardiovascular channel.
Alpha-2 agonists (clonidine, guanfacine) are central-acting antihypertensives that reduce sympathetic nervous system output. Clonidine can significantly reduce heart rate, blood pressure, and sympathetically mediated sweating, potentially affecting all three polygraph channels.
Over-the-counter sympathomimetics such as pseudoephedrine and antihistamines with anticholinergic activity like diphenhydramine can both increase heart rate and blood pressure [2]Verified Beyond the Polygraph: Deception Detection and the Autonomic Nervous System
Confirms beta-blockers reduce heart rate, heart rate variability, cardiac contractility, and blood pressure; documents that 5 of 10 most prescribed medications in 2016 had direct ANS effects; covers mefloquine and multiple medication classes affecting polygraph. These effects should not be underestimated, especially when combined with prescription medications.
Antihistamines and OTC Medications
First-Generation vs. Second-Generation Antihistamines
First-generation antihistamines (diphenhydramine/Benadryl, hydroxyzine, chlorpheniramine, promethazine) cross the blood-brain barrier and produce significant sedation and anticholinergic effects. These medications can suppress EDA by blocking acetylcholine at sweat glands, reduce cardiovascular reactivity through central sedation, and cause drowsiness that globally dampens physiological responsiveness. Their effects on polygraph testing can resemble those of benzodiazepines.
Second-generation antihistamines (cetirizine/Zyrtec, loratadine/Claritin, fexofenadine/Allegra) have minimal CNS penetration and generally produce negligible effects on polygraph channels. These are far less likely to interfere with testing.
Other OTC medications of note include decongestants containing pseudoephedrine or phenylephrine, which are sympathomimetics that can elevate heart rate and blood pressure, and NSAIDs (ibuprofen, naproxen), which generally have no significant effect on polygraph channels.
Opioids and Pain Medications
How Opioids Affect All Three Channels
Opioid medications — including oxycodone (OxyContin, Percocet), hydrocodone (Vicodin, Norco), morphine, codeine, tramadol, and fentanyl — act on mu-opioid receptors in the brain and produce widespread effects on the autonomic nervous system.
Respiratory channel: Opioids are potent respiratory depressants. They reduce respiratory rate, tidal volume, and the normal respiratory response to CO2 levels. This is often the most visibly affected channel, with shallow, slow, and regular breathing that provides less diagnostic information.
Cardiovascular channel: Opioids generally produce mild bradycardia (reduced heart rate) and vasodilation, lowering blood pressure. The cardiovascular response to stress may be blunted.
Electrodermal activity: Opioids can reduce sympathetic nervous system output, lowering skin conductance responses. However, this effect is generally less pronounced than with anticholinergic drugs.
Active psychoactive substance influence, including opioid intoxication, is generally considered a contraindication for polygraph testing [13]Verified Medical and Psychological Conditions Affecting Polygraph Examinations
Confirms that antidepressant medication may further reduce physiological reactivity in depression and that testing is contraindicated with active psychoactive substance influence. Examinees on stable, prescribed opioid therapy should disclose their medication and dosage. The examiner can then determine whether testing is appropriate and adjust interpretation accordingly.
Supplements, Herbal Remedies, and Caffeine
Common Supplements and Their Impact
Several supplements and herbal remedies have pharmacological effects that could potentially influence polygraph readings:
Caffeine is a central nervous system stimulant that increases heart rate, blood pressure, and sympathetic nervous system activity. However, for regular caffeine consumers, the effects of their normal intake are incorporated into their baseline. Examinees should maintain their normal caffeine routine rather than dramatically increasing or decreasing intake before testing.
Valerian root and kava are herbal sedatives that can produce mild anxiolytic and sedative effects, potentially reducing physiological reactivity. Their effects are generally mild compared to prescription sedatives but should still be disclosed.
St. John's Wort (Hypericum perforatum) has mild SSRI-like activity and could theoretically reduce EDA responsiveness, though the effect is likely minimal.
Melatonin, commonly used as a sleep aid, has minimal direct effects on autonomic function and is unlikely to affect polygraph results when taken the night before testing.
Antipsychotics and Mood Stabilisers
Antipsychotic Effects on Polygraph Channels
Antipsychotic medications present significant considerations for polygraph testing due to their broad pharmacological profiles:
First-generation antipsychotics (haloperidol, chlorpromazine) have strong dopamine receptor blocking activity along with anticholinergic, antihistaminic, and alpha-adrenergic blocking effects. These combined actions can suppress EDA through anticholinergic mechanisms, reduce cardiovascular reactivity, and produce sedation that globally dampens physiological responses.
Second-generation antipsychotics (quetiapine/Seroquel, olanzapine/Zyprexa, risperidone/Risperdal, aripiprazole/Abilify) have varying receptor binding profiles. Quetiapine and olanzapine tend to produce more sedation and anticholinergic effects, while aripiprazole generally has fewer effects on autonomic function.
Mood stabilisers such as lithium and valproate (Depakote) can affect autonomic function. Lithium may cause sinus node dysfunction and has various effects on the ANS. For examinees with bipolar disorder, understanding how mood stabilisers interact with polygraph testing is crucial.
Examiners working with individuals who have serious mental health conditions should also be familiar with our guides on psychopathy and polygraph testing and NPD and polygraph testing, as personality traits can interact with medication effects.
Recreational Substances and Their Impact
Alcohol, Cannabis, and Other Substances
Recreational substances can significantly affect polygraph testing and should always be disclosed:
Alcohol: Acute intoxication is a contraindication for testing. Chronic alcohol use can produce autonomic neuropathy, with research in Military Medicine noting that ANS dysfunction is a common sequela of alcoholism [2]Verified Beyond the Polygraph: Deception Detection and the Autonomic Nervous System
Confirms beta-blockers reduce heart rate, heart rate variability, cardiac contractility, and blood pressure; documents that 5 of 10 most prescribed medications in 2016 had direct ANS effects; covers mefloquine and multiple medication classes affecting polygraph. This can result in blunted physiological responses across all channels.
Cannabis/THC: Acute cannabis use can elevate heart rate and alter respiratory patterns. Chronic heavy use may produce blunted autonomic responses. THC's effects on anxiety can also complicate the emotional component of polygraph testing.
Nicotine: Acute nicotine use increases heart rate and blood pressure through sympathetic stimulation. Regular smokers should maintain their normal nicotine routine before testing — neither abstaining completely (which can cause withdrawal-related agitation) nor consuming significantly more than usual.
For families dealing with substance abuse concerns, our guide on polygraph services for uncovering substance abuse in the home provides valuable insights.
The Examiner's Suitability Assessment
How Professional Examiners Evaluate Medication Effects
A competent polygraph examiner conducts a thorough suitability assessment during the pre-test interview that includes comprehensive medication evaluation. This assessment involves documenting all current medications including dosage, frequency, and time of last dose; evaluating the potential impact of each medication on the three physiological channels; determining whether the combined medication profile creates conditions that could prevent accurate testing; and making a professional judgment about whether to proceed, postpone, or modify their approach.
The Polygraph Validation Test (PVT), developed by Tuvia Shurany and published in European Polygraph in 2015, has been demonstrated as an effective tool for resolving conflicted polygraph results. In a study of fifty-one re-examinations, the PVT was successfully employed to rectify original problems and confirm attempts by examinees at countermeasures or augmentations [14]Verified Using the Polygraph Validation Test (PVT) in Solving Conflicted Polygraph Results and Confirming Deliberate Distortions by Examinees
Confirms the PVT was successfully employed in fifty-one re-examinations to resolve conflicted outcomes and detect countermeasure attempts. This type of quality assurance methodology is particularly valuable when medication effects may have complicated initial results.
Examiners should be aware that mefloquine, an antimalarial drug used by military personnel, has been shown in murine models to disrupt autonomic and respiratory control in the central nervous system, and could affect polygraph results through both direct toxic effects on the ANS and by causing anxiety and depression [2]Verified Beyond the Polygraph: Deception Detection and the Autonomic Nervous System
Confirms beta-blockers reduce heart rate, heart rate variability, cardiac contractility, and blood pressure; documents that 5 of 10 most prescribed medications in 2016 had direct ANS effects; covers mefloquine and multiple medication classes affecting polygraph. This is especially relevant in military polygraph settings. The importance of qualified examiners in navigating these medication complexities cannot be overstated.
Disclosure: What to Tell Your Examiner
Complete Transparency Is Essential
Full medication disclosure is not just recommended — it is essential for a valid polygraph examination. You should disclose all prescription medications, including name, dosage, and when you last took them; all over-the-counter medications taken in the past 24–48 hours; all supplements, vitamins, and herbal remedies; any recreational substance use; and any recent changes to your medication regimen.
Never stop or alter your prescribed medication regimen in an attempt to improve your polygraph results. This is medically dangerous and counterproductive. An experienced examiner may recognise sudden medication changes as a potential countermeasure attempt, which could undermine confidence in the examination. Furthermore, withdrawal effects from suddenly stopping medications like benzodiazepines, SSRIs, or beta-blockers can produce physiological instability that is even more disruptive to testing than the medication itself.
The role of polygraph testing in therapeutic settings depends heavily on honest communication between all parties. Whether you are participating in a PCSOT programme, a private test, or a law enforcement examination, disclosure protects both you and the integrity of the process.
Legal and Ethical Implications
The Employee Polygraph Protection Act (EPPA)
The Employee Polygraph Protection Act of 1988 (EPPA) is a federal law that generally prevents most private employers from using polygraph tests for pre-employment screening or during the course of employment, with certain exemptions [15]Verified Employee Polygraph Protection Act of 1988
Confirms EPPA is a U.S. federal law preventing most private employers from using polygraph tests with certain exemptions. Under its permitted exemptions, the EPPA mandates specific procedural safeguards, including a minimum test duration of 90 minutes and a maximum of five polygraph tests per examiner per calendar day [16]Verified Employee Polygraph Protection Act (29 U.S.C. § 2009)
Confirms the EPPA mandates a minimum 90-minute test duration and maximum five tests per calendar day for examinations under permitted exemptions. These time requirements help ensure that examiners have adequate opportunity to conduct thorough pre-test interviews, including comprehensive medication assessments.
Government agencies — including federal, state, and local — are not covered by the EPPA [15]Verified Employee Polygraph Protection Act of 1988
Confirms EPPA is a U.S. federal law preventing most private employers from using polygraph tests with certain exemptions. Law enforcement candidates and security clearance applicants should be aware that their testing may follow different protocols but medication disclosure remains equally important.
Polygraph Evidence and Medication
The legal status of polygraph evidence varies by jurisdiction. Jan Widacki, a prominent Polish polygraph scholar, examined the evidentiary classification of polygraph results in a 2014 paper in European Polygraph, analysing whether they constitute direct or circumstantial evidence [17]Verified Results of Polygraph Examinations: Direct or Circumstantial Evidence?
Analyses whether polygraph examination results constitute direct or circumstantial evidence in legal proceedings. The paper concluded that polygraph examination results typically provide circumstantial evidence requiring interpretation within the broader context of a case [17]Verified Results of Polygraph Examinations: Direct or Circumstantial Evidence?
Analyses whether polygraph examination results constitute direct or circumstantial evidence in legal proceedings.
From a legal perspective, the presence of medications that could affect polygraph results may be raised by attorneys challenging polygraph evidence. Thorough documentation of medication status and the examiner's assessment of its potential impact is therefore critical for evidentiary reliability.
For examinees preparing for testing in specific jurisdictions, resources such as our New Jersey private polygraph testing guide and NY legal guides provide jurisdiction-specific information.
Compile Your Complete Medication List
Before your polygraph appointment, create a comprehensive list of every prescription medication, OTC drug, supplement, and herbal remedy you currently take. Include the name, dosage, frequency, and the condition each treats.
Maintain Your Normal Medication Routine
Take all prescribed medications as directed by your physician. Do not skip doses, reduce dosages, or stop any medication before your test. Withdrawal effects can be more disruptive than the medication itself.
Note Your Last Dose Timing
Record when you last took each medication before the test. Timing matters — the effects of some medications are strongest shortly after ingestion, while others have long half-lives that maintain constant blood levels.
Disclose Everything During the Pre-Test Interview
When the examiner asks about medications, provide your complete list. Include recently discontinued medications, as residual effects can persist. Mention any recent dosage changes.
Ask Questions If You Have Concerns
If you are concerned about how your medications might affect the test, raise these concerns with the examiner. A professional examiner will explain how they account for medication effects and whether testing should proceed.
Follow Post-Test Guidance
If results are inconclusive and medication is a suspected factor, discuss options with the examiner. Retesting at a different time or adjusting the testing approach may be recommended.
Pros
- An experienced examiner can adapt methodology to account for most medication effects
- Full disclosure protects both the examinee and the validity of results
- The respiratory channel often maintains diagnostic value even when other channels are affected by medication
- Modern scoring algorithms can account for suppressed reactivity in individual channels
- Research shows that common medications like therapeutic-dose methylphenidate and diazepam may not significantly impair detection accuracy in certain test formats
- The multi-channel approach of modern polygraph testing provides redundancy when one channel is affected
Cons
- Beta-blockers and benzodiazepines can produce inconclusive results by suppressing differential reactivity
- Multiple medications taken together (polypharmacy) can create complex, unpredictable interactions affecting all channels
- Some medication effects cannot be fully compensated for, requiring postponement of testing
- Anticholinergic medications can significantly suppress the EDA channel, which is normally the most informative signal
- Examinees may face pressure to stop medications before testing, which is medically inadvisable
Frequently Asked Questions
Should I tell the examiner about my prescriptions before the test?
Yes. Disclosing your medications before the examination is the recommended approach. It lets the examiner account for any physiological effects, establish an accurate baseline, and avoid misreadings. Withholding this information is more likely to cause problems, such as an inconclusive result, than disclosing it honestly.
Can the examiner postpone the test if they suspect I am medicated?
Yes. An experienced examiner can often notice when someone's physiological responses appear unusually suppressed, and may pause or reschedule the examination rather than record unreliable data. This protects the integrity of the result, so attempting to dampen your responses with substances can simply delay the process.
Do blood pressure medications affect polygraph readings?
They can. Medications that lower heart rate and blood pressure, such as beta-blockers and other antihypertensives, may reduce the physiological changes a polygraph records. This does not mean you should stop taking prescribed medication. Instead, tell the examiner so the readings can be interpreted in context.
Should I stop taking my medication before a polygraph test?
Absolutely not. Never stop or change prescribed medications without your doctor's guidance. Stopping medications can be medically dangerous and can cause withdrawal effects that disrupt testing even more than the medication itself. An experienced examiner can work with your medication profile.
Can beta-blockers help me 'beat' a polygraph test?
While beta-blockers suppress cardiovascular responses, they do not reliably allow deceptive individuals to pass. The OTA 1983 review found that propranolol primarily produced inconclusive results (32.2% inconclusive rate) rather than false passes, and the overall error rate was low [11]Verified Scientific Validity of Polygraph Testing: A Research Review and Evaluation
Confirms Gatchel et al. propranolol study showing 32.2% inconclusive rate with low overall error rate; examiners could not detect drug use in subjects; diazepam and methylphenidate did not affect detection accuracy. An experienced examiner can often recognise the characteristic suppression pattern.
Will my SSRI antidepressant affect my polygraph results?
SSRIs have relatively subtle effects on polygraph testing compared to beta-blockers or benzodiazepines. They may slightly reduce EDA responsiveness, but most examinees on stable SSRI doses can be tested successfully. Full disclosure allows the examiner to account for any effects.
How does caffeine affect a polygraph test?
Caffeine is a mild stimulant that increases heart rate and sympathetic nervous system activity. For regular caffeine consumers, maintaining your normal routine is best. Do not dramatically increase or decrease your caffeine intake before testing, as changes from your baseline are more disruptive than your normal consumption.
Can the examiner tell if I've taken a sedative before the test?
An experienced examiner can often recognise the physiological patterns associated with sedative use — globally suppressed reactivity across all channels, reduced responsiveness to both relevant and comparison questions, and overall flat tracings. The OTA report noted that the broad behavioural consequences of psychoactive drugs like diazepam should be relatively easy for an experienced examiner to detect.
What if my medication causes an inconclusive result?
An inconclusive result means the examiner could not determine a definitive outcome. This may be followed by a retest or additional investigation. If medication is suspected as a contributing factor, the examiner may recommend retesting when medication effects can be better managed, or may use the Polygraph Validation Test (PVT) to help resolve the conflicted result [14]Verified Using the Polygraph Validation Test (PVT) in Solving Conflicted Polygraph Results and Confirming Deliberate Distortions by Examinees
Confirms the PVT was successfully employed in fifty-one re-examinations to resolve conflicted outcomes and detect countermeasure attempts.
Does the EPPA require examiners to account for medication effects?
The EPPA requires a minimum 90-minute test duration for examinations conducted under its exemptions, which provides time for thorough pre-test assessment including medication evaluation [16]Verified Employee Polygraph Protection Act (29 U.S.C. § 2009)
Confirms the EPPA mandates a minimum 90-minute test duration and maximum five tests per calendar day for examinations under permitted exemptions. While the EPPA does not explicitly mandate medication assessment, professional standards and best practices require it.
Can over-the-counter antihistamines affect my polygraph test?
First-generation antihistamines like diphenhydramine (Benadryl) can significantly affect polygraph results due to their sedative and anticholinergic properties, suppressing EDA and producing drowsiness. Second-generation antihistamines like cetirizine (Zyrtec) and loratadine (Claritin) have minimal CNS effects and are much less likely to interfere with testing.
I take ADHD medication. Will it make me appear deceptive?
Stimulant ADHD medications elevate baseline arousal, which can create a noisy signal but does not specifically make you appear deceptive. Research reviewed by the OTA found that methylphenidate did not affect polygraph detection accuracy [11]Verified Scientific Validity of Polygraph Testing: A Research Review and Evaluation
Confirms Gatchel et al. propranolol study showing 32.2% inconclusive rate with low overall error rate; examiners could not detect drug use in subjects; diazepam and methylphenidate did not affect detection accuracy. Disclose your medication so the examiner can account for elevated baselines.
What about medical marijuana or CBD products?
Cannabis and THC can affect heart rate, respiratory patterns, and anxiety levels, all of which influence polygraph channels. CBD (without significant THC) has fewer autonomic effects but should still be disclosed. Always disclose all cannabis products to your examiner, regardless of legal status in your jurisdiction.
Sources & References
Confirms that drug effects on polygraph outcomes have received limited experimental attention and that different drug classes likely affect different physiological responses
Confirms beta-blockers reduce heart rate, heart rate variability, cardiac contractility, and blood pressure; documents that 5 of 10 most prescribed medications in 2016 had direct ANS effects; covers mefloquine and multiple medication classes affecting polygraph
Confirms that the electrodermal response is the most robust and informative polygraph signal, and documents anticholinergic medication effects on EDA
Confirms that examiner approach significantly impacts polygraph validity and that providing information to examinees does not impair test accuracy
Demonstrates that providing examinees with detailed CQT information and countermeasure instructions did not significantly affect test validity
Confirms 45.8% of U.S. population used one or more prescription drugs in past 30 days; 85.0% of adults aged 60+ used prescription drugs; antidepressants used by 11.4% of adults aged 20–59
Confirms adults 65+ using five or more prescription drugs increased from 33.3% to 43.0% between 2001–2004 and 2017–March 2020
Confirms more than four in ten older adults take five or more prescription medications, triple the rate from twenty years ago
Confirms more than 4 out of 10 adults 65+ reported using 5 or more prescription medications between 2017 and 2020
Confirms GSR channel was most vulnerable to beta-blocker effects while respiration channel maintained above-chance identification; conducted by the Scientific Interrogation Unit of the Israeli Police
Confirms Gatchel et al. propranolol study showing 32.2% inconclusive rate with low overall error rate; examiners could not detect drug use in subjects; diazepam and methylphenidate did not affect detection accuracy
Confirms that 24-hour sleep deprivation effects on polygraph testing accuracy were studied; energy drink consumption was also assessed
Confirms that antidepressant medication may further reduce physiological reactivity in depression and that testing is contraindicated with active psychoactive substance influence
Confirms the PVT was successfully employed in fifty-one re-examinations to resolve conflicted outcomes and detect countermeasure attempts
Confirms EPPA is a U.S. federal law preventing most private employers from using polygraph tests with certain exemptions
Confirms the EPPA mandates a minimum 90-minute test duration and maximum five tests per calendar day for examinations under permitted exemptions
Analyses whether polygraph examination results constitute direct or circumstantial evidence in legal proceedings
Foundational research on factors affecting psychophysiological detection including physiological variables and medication effects
Demonstrates that physiological response patterns in polygraph testing are influenced by the strength of memory encoding, relevant to understanding how sedative medications may affect memory-dependent physiological responses
Foundational research demonstrating that belief in physiological verification affects participant responses, relevant to understanding how medication disclosure affects the testing dynamic
A free course on how medications, stimulants and sedatives affect the physiological channels a polygraph records.
Explore the Free Course →Concerned a medication could affect results? Talk it through with a professional when you book your lie detector test near you near you.